How does intensive blood pressure control reduce the risk of cardiovascular disease events? A biomarker-based mediation analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)

被引:0
|
作者
Segar, Matthew
Khan, Safi
Nasir, Khurram
Shafi, Tariq
Januzzi, James
Arora, Pankaj
Butler, Javed
Patel, Kershaw
机构
关键词
D O I
10.1161/circ.150.suppl_1.4144426
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4144426
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial
    Upadhya, Bharathi
    Rocco, Michael
    Lewis, Cora E.
    Oparil, Suzanne
    Lovato, Laura C.
    Cushman, William C.
    Bates, Jeffrey T.
    Bello, Natalie A.
    Aurigemma, Gerard
    Fine, Lawrence J.
    Johnson, Karen C.
    Rodriguez, Carlos J.
    Raj, Dominic S.
    Rastogi, Anjay
    Tamariz, Leonardo
    Wiggers, Alan
    Kitzman, Dalane W.
    CIRCULATION-HEART FAILURE, 2017, 10 (04)
  • [42] Implications of Blood Pressure Measurement Technique for Implementation of Systolic Blood Pressure Intervention Trial (SPRINT)
    Agarwal, Rajiv
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (02):
  • [43] Intensive Versus Standard Blood Pressure Lowering and Days Free of Cardiovascular Events and Serious Adverse Events: a Post Hoc Analysis of Systolic Blood Pressure Intervention Trial
    Kim, Dae Hyun
    Tatsuoka, Curtis
    Chen, Zhengyi
    Wright, Jackson T.
    Odden, Michelle C.
    Beddhu, Srinivasan
    Bellows, Brandon K.
    Bress, Adam
    Carson, Thaddeus
    Cushman, William C.
    Johnson, Karen C.
    Morisky, Donald E.
    Punzi, Henry
    Tamariz, Leonardo
    Yang, Song
    Wei, Lee-Jen
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2022, 37 (15) : 3797 - 3804
  • [44] Intensive Versus Standard Blood Pressure Lowering and Days Free of Cardiovascular Events and Serious Adverse Events: a Post Hoc Analysis of Systolic Blood Pressure Intervention Trial
    Dae Hyun Kim
    Curtis Tatsuoka
    Zhengyi Chen
    Jackson T. Wright
    Michelle C. Odden
    Srinivasan Beddhu
    Brandon K. Bellows
    Adam Bress
    Thaddeus Carson
    William C. Cushman
    Karen C. Johnson
    Donald E. Morisky
    Henry Punzi
    Leonardo Tamariz
    Song Yang
    Lee-Jen Wei
    Journal of General Internal Medicine, 2022, 37 : 3797 - 3804
  • [45] Systolic blood pressure trajectory and cardiovascular outcomes: An analysis using data in the Systolic Blood Pressure Intervention Trial
    Lee, Chia-Lin
    Wang, Jun-Sing
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2020, 74 (03)
  • [46] The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT)
    Ambrosius, Walter T.
    Sink, Kaycee M.
    Foy, Capri G.
    Berlowitz, Dan R.
    Cheung, Alfred K.
    Cushman, William C.
    Fine, Lawrence J.
    Goff, David C., Jr.
    Johnson, Karen C.
    Killeen, Anthony A.
    Lewis, Cora E.
    Oparil, Suzanne
    Reboussin, David M.
    Rocco, Michael V.
    Snyder, Joni K.
    Williamson, Jeff D.
    Wright, Jackson T., Jr.
    Whelton, Paul K.
    CLINICAL TRIALS, 2014, 11 (05) : 532 - 546
  • [47] Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension SPRINT (Systolic Blood Pressure Intervention Trial)
    Soliman, Elsayed Z.
    Ambrosius, Walter T.
    Cushman, William C.
    Zhang, Zhu-ming
    Bates, Jeffrey T.
    Neyra, Javier A.
    Carson, Thaddeus Y.
    Tamariz, Leonardo
    Ghazi, Lama
    Cho, Monique E.
    Shapiro, Brian P.
    He, Jiang
    Fine, Lawrence J.
    Lewis, Cora E.
    CIRCULATION, 2017, 136 (05) : 440 - +
  • [48] Baseline and on-treatment serum bicarbonate, intensive blood pressure lowering, and mortality: the Systolic Blood Pressure Intervention Trial (SPRINT)
    Pareek, M.
    Byrne, C.
    Vaduganathan, M.
    Biering-Sorensen, T.
    Krogager, M. L.
    Kragholm, K. H.
    McCullough, M.
    Desai, N. R.
    Olsen, M. H.
    Bhatt, D. L.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2731 - 2731
  • [49] Re-analysis of the Systolic Blood Pressure Intervention Trial (SPRINT): The Renal Consequences of Intensive versus Standard Blood Pressure Lowering.
    Day, Branfield Leora
    Naimark, David M.
    HYPERTENSION, 2017, 70
  • [50] Evaluating the Benefit of Intensive Blood Pressure Lowering Based on Individual Outcome Profile: Post-hoc Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)
    Shi, S.
    Gouskova, N.
    Wei, L.
    Kim, D. H.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 : S85 - S86